Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia

JAMA Neurology

Volumn 73, Issue 1, 2016, Pages 93-101

  Roberts, Rosebud O ^a   Christianson, Teresa J H ^a   Kremers, Walter K ^a   Mielke, Michelle M ^a   Machulda, Mary M ^a   Vassilaki, Maria ^a   Alhurani, Rabe E ^a   Geda, Yonas E ^b   Knopman, David S ^a   Petersen, Ronald C ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ANOSMIA; ARTICLE; BRIEF SMELL IDENTIFICATION TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREND STUDY; AMNESIA; COGNITIVE DYSFUNCTION; COHORT ANALYSIS; HEALTH SURVEY; OLFACTION DISORDERS; PROCEDURES; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMNESIA; COGNITIVE DYSFUNCTION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OLFACTION DISORDERS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84954305176     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.2952     Document Type: Article

References (53)

1. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007;78(1): 30-35.
2. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007;64(7): 802-808.
3. Tabert MH, Liu X, Doty RL, et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol. 2005;58(1): 155-160.
4. Graves AB, Bowen JD, RajaramL, et al. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status. Neurology. 1999;53(7): 1480-1487.
5. Swan GE, Carmelli D. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology. 2002;21(2): 58-67.
6. Wilson RS, Arnold SE, Tang Y, Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 2006;26 (2): 61-67.
7. McShane RH, Nagy Z, Esiri MM, et al. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry. 2001;70(6): 739-743.
8. Gray AJ, Staples V, Murren K, Dhariwal A, Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 2001;16(5): 513-517.
9. Devanand DP,Michaels-Marston KS, Liu X, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 2000;157(9): 1399-1405.
10. Devanand DP, Lee S, Manly J, et al. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology. 2015; 84(2): 182-189.
11. Stanciu I, Larsson M, Nordin S, Adolfsson R, Nilsson L-G, Olofsson JK. Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: A longitudinal, population-based study. J Int Neuropsychol Soc. 2014;20(2): 209-217.
12. Devanand DP, Liu X, Tabert MH, et al. Combining early markers strongly predicts conversion frommild cognitive impairment to Alzheimer's disease. Biol Psychiatry. 2008;64(10): 871-879.
13. Kjelvik G, Sando SB, Aasly J, Engedal KA, White LR. Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease. Int J Geriatr Psychiatry. 2007; 22(10): 1020-1024.
14. Westervelt HJ, Bruce JM, CoonWG, Tremont G. Odor identification inmild cognitive impairment subtypes. J Clin Exp Neuropsychol. 2008;30(2): 151-156.
15. MakizakoM, Makizako H, Doi T, et al. Olfactory identification and cognitive performance in community-dwelling older adults with mild cognitive impairment. Chem Senses. 2014;39(1): 39-46.
16. Wang Q-S, Tian L, Huang Y-L, Qin S, He L-Q, Zhou J-N. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Res. 2002;951(1): 77-81.
17. Roberts RO, Geda YE, Knopman DS, et al. TheMayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology. 2008; 30(1): 58-69.
18. Petersen RC, Roberts RO, Knopman DS, et al; TheMayo Clinic Study of Aging. Prevalence of mild cognitive impairment is higher in men. Neurology. 2010;75(10): 889-897.
19. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3): 183-194.
20. Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology. 1993;43(11): 2412-2414.
21. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37 (3): 323-329.
22. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The short test of mental status: Correlations with standardized psychometric testing. Arch Neurol. 1991;48(7): 725-728.
23. Fahn S, Elton RL; Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease, Vol 2. FlorhamPark, NJ: MacMillan Healthcare Information; 1987: 153-163.
24. ReyA. L'examen clinique en psychologie. Paris, France: Presses Universitaires de France; 1964.
25. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's Older Americans Normative Studies: WAIS-R norms for ages 56 to 97. Clin Neuropsychol. 1992;6(sup001): 1-104. doi: 10.1080/13854049208401877.
26. Wechsler D. Manual for theWechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corp; 1987.
27. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. PerceptMot Skills. 1958;8: 271-276.
28. Lezak MD. Neuropsychological Assessment. 2nd ed. New York, NY: Oxford University Press; 1995.
29. Wechsler D.Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: Psychological Corp; 1981.
30. Kaplan E, Goodglass H,Weintraub S. The Boston Naming Test. Philadelphia, PA: Lea & Febiger; 1983.
31. Lucas JA, Ivnik RJ, Smith GE, et al. Mayo's older Americans normative studies: Category fluency norms. J Clin Exp Neuropsychol. 1998;20(2): 194-200.
32. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests. New York, NY: Oxford University Press; 2006.
33. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's Older Americans Normative Studies: WAIS-R, WMS-R and AVLT norms for ages 56 through 97. Clin Neuropsychol. 1992;6(sup001): 1-30. doi: 10.1080 /13854049208401877.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
35. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3): 263-269.
36. Doty RL, Marcus A, LeeWW. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope. 1996;106(3, pt 1): 353-356.
37. Pankratz VS, Roberts RO,Mielke MM, et al. Predicting the risk ofmild cognitive impairment in theMayo Clinic Study of Aging. Neurology. 2015;84 (14): 1433-1442.
38. AlbersMW, Gilmore GC, Kaye J, et al. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement. 2015;11(1): 70-98.
39. Doty RL. Olfaction in Parkinson's disease and related disorders. Neurobiol Dis. 2012;46(3): 527-552.
40. Kovacs T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: Olfactory bulb is involved in early Braak's stages. Neuroreport. 2001; 12(2): 285-288.
41. Lin FR,Metter EJ, O'Brien RJ, Resnick SM, Zonderman AB, Ferrucci L. Hearing loss and incident dementia. Arch Neurol. 2011;68(2): 214-220.
42. Pearson RC. Cortical connections and the pathology of Alzheimer's disease. Neurodegeneration. 1996;5(4): 429-434.
43. Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: An autopsy study. J Alzheimers Dis. 2005;7(2): 149-157.
44. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: Ameta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998;55(1): 84-90.
45. Schubert CR, Cruickshanks KJ, Fischer ME, et al. Odor identification and cognitive function in the Beaver Dam Offspring Study. J Clin Exp Neuropsychol. 2013;35(7): 669-676.
46. Suzuki Y, Yamamoto S, Umegaki H, et al. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19(8): 727-733.
47. Growdon ME, Schultz AP, Dagley AS, et al. Odor identification and Alzheimer disease biomarkers in clinically normal elderly. Neurology. 2015;84(21): 2153-2160.
48. Bacon AW, BondiMW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci. 1998;855: 723-731.
49. Salerno-Kennedy R, Cusack S, Cashman KD. Olfactory function in people with genetic risk of dementia. Ir J Med Sci. 2005;174(4): 46-50.
50. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987;18(5): 597-600.
51. Kesslak JP, Cotman CW, Chui HC, et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiol Aging. 1988;9(4): 399-403.
52. Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Olfactory impairment in older adults: Five-year incidence and risk factors. Laryngoscope. 2011;121(4): 873-878.
53. Doty RL, Frye RE, Agrawal U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys. 1989;45(5): 381-384.